InvestorsHub Logo
Followers 6
Posts 1789
Boards Moderated 0
Alias Born 04/06/2020

Re: geocam post# 19055

Monday, 08/03/2020 10:35:06 AM

Monday, August 03, 2020 10:35:06 AM

Post# of 27113
OMG, that just shows her incompetence even more, hahaha. Continue reading it.

Waterhouse continued, “Our drug testing business has been negatively impacted by the Covid-19 pandemic in the first half of 2020. The core markets for our drug tests are employment, clinical and government; and each of these sectors has been negatively impacted by the pandemic in various ways. On March 23, 2020, we announced we are distributing a rapid antibody test for Covid-19 and on May 29, 2020 this COVID-19 test was authorized by the United States Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA) for use by authorized laboratories. Starting in late March 2020, we conducted pre-sales of the product and began shipping orders to customers in May 2020. Sales of the Rapid Covid-19 test have offset the negative impact to our drug testing business. As of the date of this release, we have recorded revenues of just over $1,000,000 which resulted in approximately $430,000 in profit to ABMC after expenses and commissions.”